Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.

[1]  J. Dick,et al.  Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. , 2005, Ophthalmology.

[2]  S. Masket,et al.  Absorption of Topical Moxifloxacin Ophthalmic Solution Into Human Aqueous Humor , 2005, Cornea.

[3]  J. Crider,et al.  Ophthalmic infections and their anti-infective challenges. , 2005, Survey of ophthalmology.

[4]  W. Trattler,et al.  A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. , 2005, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[5]  J. McCulley.  Low acute endophthalmitis rate: possible explanations. , 2005, Journal of cataract and refractive surgery.

[6]  D. Bratzler,et al.  Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Jessica B. Ciralsky,et al.  Comparative Efficacy of Topical Moxifloxacin Versus Ciprofloxacin and Vancomycin in the Treatment of P. aeruginosa and Ciprofloxacin-Resistant MRSA Keratitis in Rabbits , 2005, Cornea.

[8]  T. O'brien,et al.  Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery , 2005, Current medical research and opinion.

[9]  C. Nedrud,et al.  Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. , 2004, Ophthalmology.

[10]  J. Stewart,et al.  The effect of cataract surgery on ocular levels of topical moxifloxacin. , 2004, American journal of ophthalmology.

[11]  J. Blondeau,et al.  Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. , 2004, International journal of antimicrobial agents.

[12]  F. Mah.  Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections , 2004, Current opinion in ophthalmology.

[13]  E. Romanowski,et al.  Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. , 2004, American journal of ophthalmology.

[14]  D. Bratzler,et al.  Antimicrobial Prophylaxis for Surgery: An Advisory Statement from the National Surgical Infection Prevention Project , 2004 .

[15]  W. Petroll,et al.  Evaluation of the Corneal Effects of Topical Ophthalmic Fluoroquinolones Using In Vivo Confocal Microscopy , 2004, Eye & contact lens.

[16]  J. Crider,et al.  Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. , 2004, Clinical therapeutics.

[17]  F. Bucci.  An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification. , 2004, American journal of ophthalmology.

[18]  E. Romanowski,et al.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. , 2003, American journal of ophthalmology.

[19]  Zhongping Chen,et al.  Dynamic morphology of clear corneal cataract incisions. , 2003, Ophthalmology.

[20]  W. Culbertson,et al.  Infectious keratitis after LASIK. , 2003, Ophthalmology.

[21]  Y. Nagaki,et al.  Bacterial endophthalmitis after small‐incision cataract surgery: Effect of incision placement and intraocular lens type , 2003, Journal of cataract and refractive surgery.

[22]  K. Dobbins,et al.  Penetration of topically administered ofloxacin and trimethoprim into aqueous humor. , 2002, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[23]  David V Leaming,et al.  Practice styles and preferences of ASCRS members—2001 survey , 2002, Journal of cataract and refractive surgery.

[24]  K. Sowinski,et al.  Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  E. Romanowski,et al.  Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. , 2002, American journal of ophthalmology.

[26]  Jerome J. Schentag.  Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae. , 2002, Journal of chemotherapy.

[27]  P. Iannini,et al.  Un Aggiornato Profilo di Sicurezza della Moxifloxacina , 2002, Journal of chemotherapy.

[28]  D. Leaming.  Practice styles and preferences of ASCRS members—2000 survey , 2001, Journal of cataract and refractive surgery.

[29]  B. Shingleton,et al.  Evaluation of intraocular pressure in the immediate period after phacoemulsification , 2001, Journal of cataract and refractive surgery.

[30]  W. Hamilton,et al.  Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. , 2000, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[31]  Michael H. Miller,et al.  Pharmacokinetics of Sparfloxacin in the Serum and Vitreous Humor of Rabbits: Physicochemical Properties That Regulate Penetration of Quinolone Antimicrobials , 1998, Antimicrobial Agents and Chemotherapy.

[32]  S. Wisniewski,et al.  Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. , 1996, American journal of ophthalmology.

[33]  R. Paluzzi,et al.  Antimicrobial prophylaxis for surgery. , 1993, The Medical clinics of North America.

[34]  J. Rowsey,et al.  Infectious endophthalmitis following sutureless cataract surgery. , 1991, Archives of ophthalmology.

[35]  H. Neu,et al.  The inhibitory quotient. , 1983, Bulletin of the New York Academy of Medicine.